SuissaKSchneeweissSKimDWPatornoE. Prescribing trends and clinical characteristics of patients starting antiobesity drugs in the United States. Diabetes Obes Metab. 2021;23(7):1542-1551.
2.
JoHSWangSMKimJJ. Recurrent psychosis after phentermine administration in a young female: a case report. Clin Psychopharmacol Neurosci. 2019;17(1):130-133.
3.
KumarSMogalapalliASrinivasamurthyR, et al. Supraventricular tachycardia with the use of phentermine: case report and review of literature. Postgrad Med. 2021;133(4):454-457.
4.
SteidlKEDarkoWProbstLANoviaskyJANasserS. Rhabdomyolysis associated with phentermine. Am J Health Syst Pharm. 2010;67(22):1929-1932.
5.
NaranjoCABustoUSellersEM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.
